A Proof-Of-Principle Study of Epigenetic Therapy Added to Neoadjuvant Doxorubicin Cyclophosphamide for Locally Advanced Breast Cancer

Overview of attention for article published in PLOS ONE, December 2006

Altmetric Badge

Mentioned by

blogs: 1 blog
twitter: 1 X user

patent: 6 patents

Citations

dimensions_citation: 122 Dimensions

Readers on

mendeley: 115 Mendeley
connotea: 1 Connotea

Summary Blogs X Patents Dimensions citations

So far, Dimensions has found 122 publications that cite this research output.

122

The most recent citing publications are shown below. View all 122 publications that cite this research output on Dimensions.

Research progress and applications of epigenetic biomarkers in cancer

Article in Frontiers in Pharmacology (April 2024)

Epigenetic deregulation in breast cancer microenvironment: Implications for tumor progression and therapeutic strategies

Article in Biomedicine & Pharmacotherapy (April 2024)

Synergistic combination of doxorubicin with hydralazine, and disulfiram against MCF-7 breast cancer cell line

Article in PLOS ONE (September 2023)